MEDULLOBLASTOMA
Clinical trials for MEDULLOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new MEDULLOBLASTOMA trials appear
Sign up with your email to follow new studies for MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tailored brain cancer therapy aims to cut toxicity in young patients
Disease control TerminatedThis study tested a personalized approach for teenagers and young adults with a rare brain tumor called medulloblastoma. It aimed to see if giving a targeted drug (sonidegib) along with lower radiation doses could improve outcomes and reduce side effects. The trial was stopped ea…
Matched conditions: MEDULLOBLASTOMA
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Promising drug tested for childhood brain cancer relapse
Disease control TerminatedThis study looked at a drug called CX-4945 for children whose SHH medulloblastoma (a type of brain tumor) had come back. It involved 21 participants and aimed to find the safest dose and see if the drug could shrink tumors. The study was stopped early, so results are limited.
Matched conditions: MEDULLOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Could a simple fluid test replace brain surgery for kids with tumors?
Knowledge-focused TerminatedThis study looked at whether a liquid biopsy—testing the fluid around the brain and spinal cord—can find tumor DNA in children and young adults with brain tumors. Researchers collected extra samples during routine care from up to 57 participants. The goal was to see if this safer…
Matched conditions: MEDULLOBLASTOMA
Sponsor: Pediatric Brain Tumor Consortium • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC